These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 28490883)

  • 1. Retrospective analysis of non-laboratory-based adverse drug reactions induced by intravenous radiocontrast agents in a Joint Commission International-accredited academic medical center hospital in China.
    Chen QL; Zhao XY; Wang XM; Lv N; Zhu LL; Xu HM; Zhou Q
    Ther Clin Risk Manag; 2017; 13():565-573. PubMed ID: 28490883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical observation of the adverse drug reactions caused by non-ionic iodinated contrast media: results from 109,255 cases who underwent enhanced CT examination in Chongqing, China.
    Li X; Chen J; Zhang L; Liu H; Wang S; Chen X; Fang J; Wang S; Zhang W
    Br J Radiol; 2015 Mar; 88(1047):20140491. PubMed ID: 25582519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Varied incidence of immediate adverse reactions to low-osmolar non-ionic iodide radiocontrast media used in computed tomography.
    Kim SR; Lee JH; Park KH; Park HJ; Park JW
    Clin Exp Allergy; 2017 Jan; 47(1):106-112. PubMed ID: 27648932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intradermal Testing With Radiocontrast Media to Prevent Recurrent Adverse Reactions.
    Kim SR; Park KH; Hong YJ; Oh YT; Park JW; Lee JH
    AJR Am J Roentgenol; 2019 Dec; 213(6):1187-1193. PubMed ID: 31414881
    [No Abstract]   [Full Text] [Related]  

  • 5. Safety of non-ionic contrast media in CT examinations for out-patients: retrospective multicenter analysis of 473,482 patients.
    Zeng W; Tang J; Xu X; Zhang Y; Zeng L; Zhang Y; Liang Z; Xia C; Zhao L; Li Z
    Eur Radiol; 2024 Sep; 34(9):5570-5577. PubMed ID: 38457038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences in Adverse Reactions Among Iodinated Contrast Media: Analysis of the KAERS Database.
    An J; Jung H; Kwon OY; Kang Y; Lee JH; Won HK; Song WJ; Kwon HS; Cho YS; Moon HB; Kim TB
    J Allergy Clin Immunol Pract; 2019; 7(7):2205-2211. PubMed ID: 30877072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences in the Recurrence Rate of Immediate Adverse Drug Reactions According to the Components of Alternative Contrast Media: Analysis of Repetitive Computed Tomography Cases in a Single Tertiary Hospital.
    Kim SR; Son NH; Park HJ; Park KH; Park JW; Lee JH
    Drug Saf; 2022 Sep; 45(9):995-1002. PubMed ID: 35908149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Post-marketing surveillance study with iodixanol in 20 185 Chinese patients from routine clinical practices.
    Zhang BC; Hou L; Lv B; Xu YW
    Br J Radiol; 2014 Feb; 87(1034):20130325. PubMed ID: 24357597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contrast Media Adverse Drug Reactions in Highly Polluted Environment.
    Sauer N; Szlasa W; Jonderko L; Głowacka K; Karłowicz-Bodalska K; Wiela-Hojeńska A
    Int J Environ Res Public Health; 2022 Jun; 19(12):. PubMed ID: 35742323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Incidence, Classification, and Management of Acute Adverse Reactions to the Low-Osmolar Iodinated Contrast Media Isovue and Ultravist in Contrast-Enhanced Computed Tomography Scanning.
    Zhang B; Dong Y; Liang L; Lian Z; Liu J; Luo X; Chen W; Li X; Liang C; Zhang S
    Medicine (Baltimore); 2016 Mar; 95(12):e3170. PubMed ID: 27015204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety aspects of iodinated contrast media related to their physicochemical properties: a pharmacoepidemiology study in two Tuscany hospitals.
    Lapi F; Cecchi E; Pedone C; Attanasio F; Banchelli G; Vannacci A; Di Pirro M; Moschini M; Berni V; Matucci R; Cini E; Scalia A; Tendi E; Mugelli A
    Eur J Clin Pharmacol; 2008 Jul; 64(7):723-37. PubMed ID: 18401577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical safety evaluation of contrast agents based on real-world evidence.
    Jiang C; Li J; Huang Y; Huang D; Lin J; Jiang X
    J Clin Pharm Ther; 2021 Dec; 46(6):1600-1605. PubMed ID: 34293194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of the Radio-contrast Media-Induced Self-Reported Adverse Drug Reactions in a Tertiary Care Hospital of North India: A Prospective Study.
    Singh P; Gill MK; Kaur M; Mahajan R; Kaur M
    Int J Appl Basic Med Res; 2022; 12(1):14-17. PubMed ID: 35265475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adverse Drug Reactions to Radiographic Contrast Media in a Teaching Hospital in North India: An Observational Study.
    Chopra D; Jain A; Garg R; Dhingra S
    Curr Drug Saf; 2019; 14(2):122-126. PubMed ID: 30666915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical features and risk factors of iodinated contrast media (ICM)-induced anaphylaxis.
    Fukushima Y; Taketomi-Takahashi A; Suto T; Hirasawa H; Tsushima Y
    Eur J Radiol; 2023 Jul; 164():110880. PubMed ID: 37187078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and tolerability of iopromide in patients undergoing cardiac catheterization: real-world multicenter experience with 17,513 patients from the TRUST trial.
    Chen JY; Liu Y; Zhou YL; Tan N; Zhang B; Chen PY; Chen LB
    Int J Cardiovasc Imaging; 2015 Oct; 31(7):1281-91. PubMed ID: 26058857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of acute reactions to iopromide: postmarketing surveillance study of 74,717 patients.
    Kopp AF; Mortele KJ; Cho YD; Palkowitsch P; Bettmann MA; Claussen CD
    Acta Radiol; 2008 Oct; 49(8):902-11. PubMed ID: 18651252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of patient comfort between iodixanol and iopamidol in contrast-enhanced computed tomography of the abdomen and pelvis: a randomized trial.
    Weiland FL; Marti-Bonmati L; Lim L; Becker HC
    Acta Radiol; 2014 Jul; 55(6):715-24. PubMed ID: 24060817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monitoring drug safety in Astrakhan, Russia.
    Kirilochev OO; Dorfman IP; Umerova AR
    Int J Risk Saf Med; 2015; 27 Suppl 1():S33-4. PubMed ID: 26639700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N-(2,3-dihydroxypropyl) carbamoyl side chain: a potentially significant factor for recurrent iodinated contrast medium-related adverse drug reactions.
    Kim PH; Suh CH; Jang EB; Kim S; Park KJ; Park HJ; Kim AY; Do KH; Lee JH; Kim JH; Jung AY; Lee CW
    Eur Radiol; 2024 Oct; 34(10):6444-6453. PubMed ID: 38625610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.